Clinical trial Recruiting at 3 sites Interventional Ages 18 to 60 Women only

Remote monitoring program for postpartum hypertension in Rhode Island

Official title: Effect of a Technology-based Collaborative Model on Persistent Hypertension and Preventive Care Attendance Among Postpartum People With Hypertensive Disorders of Pregnancy

Run by Women and Infants Hospital of Rhode Island · NCT06842875 · Data updated 2026-11-12

This study is testing a new remote monitoring program for postpartum hypertension to see if it helps new moms manage their blood pressure better than the usual self-check methods.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexWomen only
Enrollment1536 (estimated)
SponsorWomen and Infants Hospital of Rhode Island
Academic / other
Locations5 sites (Newport, Rhode Island and 4 other locations)
StatusRecruiting
StartedApril 15, 2025
Main results expectedMarch 1, 2029
Study endsMarch 1, 2029
Registry record updatedJune 17, 2025
Trial IDNCT06842875 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include postpartum patients aged 18 or older who have been diagnosed with a hypertensive disorder during pregnancy or after delivery and can communicate in English, Spanish, Portuguese, or Haitian-Creole.

Probably not a fit

Patients who are incarcerated or unable to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of the Rhode Island Statewide Postpartum Hypertension Remote Surveillance (RI-SPHERES) program, which utilizes a collaborative care model to manage postpartum hypertension. It compares this technologically enabled program to a standard self-measured blood pressure (SMBP) approach, focusing on persistent hypertension at six weeks postpartum and preventive care within one year of delivery. The study aims to address barriers to in-person care, particularly for racial and ethnic minority patients, by providing remote monitoring and support. A total of 1,536 postpartum patients diagnosed with hypertensive disorders will participate in this hybrid implementation effectiveness trial.

Why it matters

Potential benefit: If successful, this program could significantly improve the management of postpartum hypertension and reduce health disparities among affected populations.

How similar studies have gone: While some studies have shown promise with self-measured blood pressure programs, this approach is novel in its focus on a collaborative care model specifically targeting postpartum hypertension.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island
* Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnant
* English-, Spanish-, Portuguese-, or Haitian-Creole-speaking
* Smartphone ownership

Exclusion Criteria:

* Prior enrollment in this trial
* Prisoners or incarcerated people
* Inability or unwillingness to provide informed consent
* Inability to communicate with study team, despite an interpreter

Where it's running

  • Women & Infants Hospital of Rhode Island
    Providence, Rhode Island, United States
    Recruiting
  • Kent Hospital
    Warwick, Rhode Island, United States
    Recruiting
  • Landmark Hospital
    Woonsocket, Rhode Island, United States
    Recruiting
  • Newport Hospital
    Newport, Rhode Island, United States
    Not yet recruiting
  • South County Hospital
    Wakefield, Rhode Island, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.